9th Circ. Nixes Pharmacies' Pfizer-Wyeth Merger Suit

Law360, New York (May 20, 2011, 3:25 PM EDT) -- The Ninth Circuit on Thursday upheld the dismissal of a group of pharmacies' antitrust challenge to Pfizer Inc.'s $68 billion merger with Wyeth, saying the pharmacies failed to specify a relevant product market that would be harmed by the merger.

The seven pharmacies in the long-running case claim the deal — which was completed in 2009 — ran afoul of Section 7 of the Clayton Act and Section 1 of the Sherman Act because Pfizer and Wyeth directly competed with each other in various submarkets of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.